Platelet-bound cyclophilin A in patients with stable coronary artery disease and acute myocardial infarction

Platelets

Volumn 27, Issue 2, 2016, Pages 155-158

  Seizer, Peter ^a   Fuchs, Christian ^a   Ungern Sternberg, Saskia N I V ^a   Heinzmann, David ^a   Langer, Harald ^a   Gawaz, Meinrad ^a   May, Andreas E ^a   Geisler, Tobias ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Acute coronary syndrome; Cyclophilin A; platelets; thrombosis

Indexed keywords

CYCLOPHILIN A; PADGEM PROTEIN; PROTEIN BINDING;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOCYTE MEMBRANE; BLOOD; COMPLICATION; DIABETES MELLITUS; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; SMOKING; THROMBOCYTE ACTIVATION; UNSTABLE ANGINA PECTORIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; BLOOD PLATELETS; CORONARY ARTERY DISEASE; CYCLOPHILIN A; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PROTEIN BINDING; RISK FACTORS; SMOKING;

EID: 84959163756     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2015.1051466     Document Type: Article

References (22)

1. Fischer G, Schmid FX. The mechanism of protein folding. Implications of in vitro refolding models for de novo protein folding and translocation in the cell. Biochemistry 1990; 29: 2205-2212
2. Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid FX. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989; 337: 476-478
3. Colgan J, Asmal M, Neagu M, Yu B, Schneidkraut J, Lee Y, Sokolskaja E, Andreotti A, Luban J. Cyclophilin A regulates TCR signal strength in CD4+ T cells via a proline-directed conformational switch in Itk. Immunity 2004; 21: 189-201
4. Elvers M, Herrmann A, Seizer P, Munzer P, Beck S, Schonberger T, Borst O, Martin-Romero FJ, Lang F, May AE, et al. Intracellular cyclophilin A is an important Ca2+ regulator in platelets and critically involved in arterial thrombus formation. Blood 2012; 120: 1317-1326
5. Wang L, Soe NN, Sowden M, Xu Y, Modjeski K, Baskaran P, Kim Y, Smolock EM, Morrell CN, Berk BC. Cyclophilin A is an important mediator of platelet function by regulating integrin alphaIIbbeta3 bidirectional signalling. Thromb Haemost 2014; 111: 873-882
6. Seizer P, Gawaz M, May AE. Cyclophilin A and EMMPRIN (CD147) in cardiovascular diseases. Cardiovasc Res 2014; 102: 17-23
7. Seizer P, Schonberger T, Schott M, Lang MR, Langer HF, Bigalke B, Krämer BF, Borst O, Daub K, Heidenreich O, et al. EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis 2010; 209: 51-57
8. Jin ZG, Melaragno MG, Liao DF, Yan C, Haendeler J, Suh YA, Lambeth JD, Berk BC. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 2000; 87: 789-796
9. Ramachandran S, Venugopal A, Sathisha K, Reshmi G, Charles S, Divya G, Chandran NS, Mullassari A, Pillai MR, Kartha CC. Proteomic profiling of high glucose primed monocytes identifies cyclophilin A as a potential secretory marker of inflammation in type 2 diabetes. Proteomics 2012; 12: 2808-2821
10. Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maguire PB. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 2004; 103: 2096-2104
11. Seko Y, Fujimura T, Taka H, Mineki R, Murayama K, Nagai R. Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem Biophys Res Commun 2004; 317: 162-168
12. Yurchenko V, Zybarth G, O'Connor M, Dai WW, Franchin G, Hao T, Guo H, Hung HC, Toole B, Gallay P, et al. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem 2002; 277: 22959-22965
13. Yurchenko V, Constant S, Bukrinsky M. Dealing with the family: CD147 interactions with cyclophilins. Immunology 2006; 117: 301-309
14. Sturhan H, Ungern-Sternberg SN, Langer H, Gawaz M, Geisler T, May AE, Seizer P. Regulation of EMMPRIN (CD147) on monocyte subsets in patients with symptomatic coronary artery disease. Thromb Res 2015; 135: 1160-1164
15. Seizer P, Ungern-Sternberg SN, Schonberger T, Borst O, Munzer P, Schmidt E, Mack AF, Heinzmann D, Chatterjee M, Langer H, et al. Extracellular cyclophilin A activates platelets Via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo. Arterioscler Thromb Vasc Biol 2015;35:655-663
16. Satoh K, Fukumoto Y, Sugimura K, Miura Y, Aoki T, Nochioka K, Tatebe S, Miyamichi-Yamamoto S, Shimizu T, Osaki S, et al. Plasma cyclophilin A is a novel biomarker for coronary artery disease. Circ J 2012; 77: 447-455
17. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, et al. 2013. ESH/ESC guidelines for the management of arterial hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-1357
18. Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, et al. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD-summary. Diab Vasc Dis Res 2014;11:133-173
19. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons, Thygesen K, Alpert JS, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60: 1581-1598
20. Chang CS, Su SL, Chang CC, Lee KW, Kuo CL, Huang CS, Tseng WM, Liu CS. Cyclophilin-A: A novel biomarker for untreated male essential hypertension. Biomarkers 2013; 18: 716-720
21. Schmidt R, Bultmann A, Ungerer M, Joghetaei N, Bulbul O, Thieme S, Chavakis T, Toole BP, Gawaz M, Schömig A, et al. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: Implications in acute myocardial infarction. Circulation 2006; 113: 834-841
22. Egawa N, Koshikawa N, Tomari T, Nabeshima K, Isobe T, Seiki M. Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells. J Biol Chem 2006; 281: 37576-37585